ArticleInternational journal of clinical and experimental pathology2018
Mucinous gastric carcinoma: an update of clinicopathologic features and prognostic value from a retrospective study of clinical series.
Article in International journal of clinical and experimental pathology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed, 6 citations in OpenAlex.
- Impact of Neoadjuvant Chemotherapy on Prognosis of Patients with Mucinous Gastric Adenocarcinoma: A Propensity Score Matching Study.Annals of surgical oncology · 2026Article
- Gastric mucinous adenocarcinoma presenting with chronic cough, bronchovascular bundle thickening, and multiple pulmonary nodules: a case report.Frontiers in oncology · 2026Article
- Histopathological response to chemotherapy and survival of mucinous type gastric cancer.Journal of the National Cancer Institute · 2025Article
- A survival comparison of gastric mucin-producing adenocarcinoma to conventional adenocarcinoma: a SEER database analysis.BMC cancer · 2021Article
- Deep Learning for Automatic Subclassification of Gastric Carcinoma Using Whole-Slide Histopathology Images.Cancers · 2021Article
- Clinical Outcomes of Mucinous Gastric Carcinomas Compared with Non-mucinous and Signet Ring Cell Carcinomas.The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Mucinous gastric carcinoma (MGC) is a specific type of gastric carcinoma, but its clinicopathologic characteristics remains obscured. Our study aimed to explore clinical features and prognostic value of MGC. This retrospective study included a total of 996 patients with primary gastric carcinoma from June 1994 to December 2006. Patients with gastric carcinoma were divided into MGC, other poorly differentiated (PD), and well or moderately differentiated groups. In all, 68 (6.8%) of 996 patients had MGC, with 599 (60.2%) cases for PD. Our study found that MGC had older age, more distant and peritoneal metastasis, but less radical gastrectomy than PD. Furthermore, the overall survival rate of MGC declined compared with PD gastric cancer (22.3% vs. 28.8%, P=0.032). Younger age (≤60 ys), smaller size (≤5 cm), Bormann III type, and lymph node metastasis were linked to poorer prognosis of MGC. However, MGC itself was not an independent prognostic factor of gastric carcinoma. In conclusion, MGC was associated with poorer prognosis than other types of gastric carcinoma but was not an independent predictive factor for survival, which called for further lucubration of this distinctive type of gastric carcinoma.
Indexed as
Identifiers
31938170PMC6958002W3027820447What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.